Reunion Neuroscience (TSX:REUN) Inventory-to-Revenue : 0.00 (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Reunion Neuroscience's Average Total Inventories for the quarter that ended in Mar. 2023 was C$0.00 Mil. Reunion Neuroscience's Revenue for the three months ended in Mar. 2023 was C$0.00 Mil.

Reunion Neuroscience's Inventory-to-Revenue for the quarter that ended in Mar. 2023 stayed the same from Dec. 2022 (0.00) to Dec. 2022 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Reunion Neuroscience Inventory-to-Revenue Historical Data

The historical data trend for Reunion Neuroscience's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Inventory-to-Revenue Chart

Reunion Neuroscience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Inventory-to-Revenue

Reunion Neuroscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Inventory-to-Revenue	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Reunion Neuroscience's Inventory-to-Revenue

For the Biotechnology subindustry, Reunion Neuroscience's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reunion Neuroscience's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reunion Neuroscience's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Reunion Neuroscience's Inventory-to-Revenue falls into.

Reunion Neuroscience Inventory-to-Revenue Calculation

Reunion Neuroscience's Inventory-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

	Inventory-to-Revenue (A: Mar. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=	N/A

Reunion Neuroscience's Inventory-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

	Inventory-to-Revenue (Q: Mar. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Dec. 2022 )	+	Total Inventories (Q: Mar. 2023 ))	/	count )	/	Revenue (Q: Mar. 2023 )
=	( (0	+	0)	/	1 )	/	0
=	0					/	0
=

Reunion Neuroscience (TSX:REUN) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Reunion Neuroscience's Days Inventory for the three months ended in Mar. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2023 )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Reunion Neuroscience's Inventory Turnover for the quarter that ended in Mar. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2023 )	/	Average Total Inventories (Q: Mar. 2023 )
	=	0	/	0
	=

Reunion Neuroscience Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Reunion Neuroscience (TSX:REUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3

Website

https://www.reunionneuro.com

Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.